Qiagen Enters Neurology Space with Parkinson’s CDx Collaboration
The developer of NGS-based companion diagnostics targets the growing neurology biomarker market.
The developer of NGS-based companion diagnostics targets the growing neurology biomarker market.
Two lab staffing experts weigh in on current trends and what labs need to do to attract and retain talent in today’s environment.
Retailer stubs a toe on its way to disrupting health care.
Based on validation study data, the test offers 90 percent accuracy and is unaffected by the emergence of new COVID-19 variants.
While the rule is not yet final, it’s likely that labs will have to pay more in direct CLIA compliance expenses, starting in October.